About PGZ Immune
Clinic’s Journey
32 Years Of Experience in Medical Services
Since our inception in 1993, Praxisgemeinschaft für Zelltherapie (PGZ) has been a pioneer in immunological cellular therapeutics. Our journey began in a single laboratory in Duderstadt, where we spent nearly two decades conducting groundbreaking research. In 2011, we took a significant leap forward by expanding our operations to a state-of-the-art 4000 square foot facility in Nordhäuser Str., Duderstadt. This expansion has enabled us to enhance our capabilities in manufacturing advanced cellular therapeutics, solidifying our position as leaders in the field.
Achievements
- 2012: Granted manufacturing license for somatic cellular therapies (§13 subsection 1, German drug law)
- 2011: Completed construction of new 4000 square feet laboratory facility
- Continuous modernization and refurbishment of facilities since 1993
- Establishment of a quality management system operating at pharmaceutical industry standards
- Compliance with national and international laws and guidelines in cellular therapeutics manufacturing
History About Praxisgemeinschaft für Zelltherapie
- 1984:First active specific immunotherapy (ASI) with autologous tumour lysates in patients with ovarian carcinomas at the University Gynaecological Hospital in Göttingen (Dr. T. Neßelhut)
- 1987: First description of antigen-presenting cells isolated from monocytes (Professor Dr. J. H. Peters)
- 1992: Founding of the Neßelhut practice with oncological focus and treatment of patients with active specific immunotherapy in Duderstadt (Dr. T. Neßelhut)
- 1996: Founding of the Institute for Tumour Therapy (Dr. T. Neßelhut)
- 1999: Therapy of gynaecological-oncological patients with dendritic cells at the University Gynaecological Hospital in Göttingen (Dr. K. Neßelhut)
- 2000 – 2006: Manufacturing authorisation for active specific immunotherapies with authorisation for administration (Dr. T. Neßelhut)
- 2004: Dr. J. Neßelhut became a partner in the Neßelhut practice
- 2008: Founding of the Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG
(Joint Practice for Cell Therapy in Duderstadt) (Dr. T. Neßelhut, Dr. J. Neßelhut)
- 2009: Dr. Dr. M. Martin, Dr. K. Briken, and Dr. W.P. Brockmann became partners in the Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG
- 2005-2010: Sponsoring of research projects in the years 2005 – 2010 with funding of the Society for Biological Cancer Defence at the Forschungszentrum Jülich GmbH (Jülich Research Centre, Berlin site) and with funding of the European Fund for Regional Development and the German State of Lower Saxony
- 2010: Dr. K. Neßelhut became a partner in the practice of Dres. Neßelhut and the Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG
- 2011: Opening of the new clean room laboratory at the Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG with a temporary authorisation for somatic cell therapeutics sponsored by the European Union
- 2012: Granting of a personalised authorisation for the manufacturing of somatic cell therapeutics for the doctors of the Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG in accordance with Article 13, Paragraph 1 of the Medicinal Products Act
How We Work
Our mission is to revolutionize treatment options by leveraging the power of the immune system to combat a wide range of diseases.
To harness the latest immunological advancements for the benefit of our patients
To maintain the highest technological and scientific standards in all our operations
To offer innovative cell-based immunotherapies across various medical specialties
Our Satisfied Patients
Elma
PGZ IMMUNE has been a game-changer for my health! I feel more energized, resilient, and confident knowing I’m giving my immune system the support it needs. The quality and effectiveness are unmatched highly recommend!